1660 |
FATE-MAIN Trial |
Duk-Woo Park |
Apr. 20. 23 |
1659 |
RENOVATE Trial |
Ho Jin Kim |
Apr. 20. 23 |
1658 |
EPIC-CAD Trial |
Min Soo Cho |
Apr. 20. 23 |
1657 |
ASSURE-DES Trial |
Jung-Min Ahn |
Apr. 20. 23 |
1656 |
TAILRORED-CHIP Trial |
Duk-Woo Park |
Apr. 20. 23 |
1655 |
PREVENT Trial |
Seung-Jung Park |
Apr. 20. 23 |
1654 |
OCTIVUS Trial |
Do-Yoon Kang |
Apr. 20. 23 |
1653 |
Anticoagulation vs. Antiplatelet After TAVR: ADAPT-TAVR Trial |
Duk-Woo Park |
Apr. 20. 23 |
1652 |
10-Year Extended Follow-up of BEST Trial |
Jung-Min Ahn |
Apr. 20. 23 |
1651 |
Routine Functional Testing or Standard Care in High-Risk Patients after PCI |
Do-Yoon Kang |
Apr. 20. 23 |